Newswise - Premature ejaculation (PE) is defined as "persistent or recurrent onset of orgasm and ejaculation with minimal sexual stimulation before, on, or shortly after penetration and before the person wishes it."
The psychological elements of distress and dissatisfaction may account for the traditional view of PE as a psychological condition. It has recently been suggested that PE might be associated with perturbations in serotonergic 5-hydroxytrptamine (5-HT) neurotransmission. This had led to the development of targeted therapies for PE that might alter the 5-HT system.
In a recent study by Francisco Giuliano from Garches Frances studies the efficacy of a novel therapeutic agent, dapoxetine, for the treatment of premature ejaculation. The study is published in the July 2007 European Urology Supplements.
Finally. This is science. There’s a control group. There are two experimental groups. They have 2,600 test subjects. They have a specific hypothesis to test out and a clear and stated result. This is how you do it. This is how you science. They could be testing whether Coke or Pepsi help you grow hair back for all we care, as long as they’re following the scientific method, we DIG IT. So, the deal is that dapoxetine works to correct premature ejaculation. It increases the time the dudes last. The mean time of Intervaginal Ejaculatory Latency Time (IELT, by the way, we just lost a buck to ourselves for putting Intervaginal, Ejaculatory, Latency and Time in the same sentence) increases from 1.75 to 3.32 minutes (from the control group to max dosage). Maybe they should title Dapoxetine: A Coming Of Age Tale. They’re never going to sell dapoxetine on the open market. They need to get a cool name like Longlastia.